In the published article, there was an error in the Funding statement. The BHF Funding grant number was missing. The correct Funding statement appears below.
Statements
Funding
This study was supported by the grants from the Sir Jules Thorn Charitable Trust (MC and PM), the Enid Linder Foundation (MC), the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre in Cardiovascular Medicine (MC and PM), the British Heart Foundation (no. PG/18/38/33707) grant entitled “Microfabrication and in vivo testing of small-diameter tissue-engineered vascular grafts” (PM), and the Medical Research Council (no. MR/N027086/1) grant entitled “In vitro and in vivo preclinical testing of pericyte-engineered grafts for correction of congenital heart defects” (PM and MC).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
aging, congenital defect, proteostasis, inflammation, surgery, extracorporeal bypass
Citation
Iacobazzi D, Alvino VV, Caputo M and Madeddu P (2022) Corrigendum: Accelerated cardiac aging in patients with congenital heart disease. Front. Cardiovasc. Med. 9:1112510. doi: 10.3389/fcvm.2022.1112510
Received
30 November 2022
Accepted
05 December 2022
Published
15 December 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
9 - 2022
Updates
Copyright
© 2022 Iacobazzi, Alvino, Caputo and Madeddu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paolo Madeddu ✉paolo.madeddu@bristol.ac.uk
This article was submitted to Cardiovascular Biologics and Regenerative Medicine, a section of the journal Frontiers in Cardiovascular Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.